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Background: Denmark has inferior cancer survival rates compared with many European countries. The main
reason for this is suggested to be late diagnosis at advanced cancer stages. Cancer diagnostic work-up begins in
general practice in 85% of all cancer cases. Thus, general practitioners (GPs) play a key role in the diagnostic
process. The latest Danish Cancer Plan included continuing medical education (CME) on early cancer diagnosis in
general practice to improve early diagnosis. This dual aims of this protocol are, first, to describe the conceptualisation,
operationalisation and implementation of the CME and, second, to describe the study design and outcomes chosen to
evaluate the effects of the CME.
Methods/Design: The intervention is a CME in early cancer diagnosis targeting individual GPs. It was developed
by a step-wise approach. Barriers for early cancer diagnosis at GP level were identified systematically and analysed
using the behaviour system involving capability, opportunity and motivation described by Michie et al. The study
will be designed as a geographical cluster randomised stepped wedge study. The study population counts 836
GPs from 417 general practices in the Central Denmark Region, geographically divided into eight clusters. GPs
from each cluster will be invited to a CME meeting at a certain date three weeks apart. The primary outcomes will
be primary care interval and GP referral rate on cancer suspicion. Data will be obtained from national registries,
GP-completed forms on patients referred to cancer fast-track pathways and GP-completed online questionnaires
before and after the intervention.
Discussion: To our knowledge, this will be the first study to measure the effect of a theory-based CME in early
cancer diagnosis at three levels: GP knowledge and attitude, GP activity and patient outcomes. The achieved
knowledge will contribute to the understanding of whether and how general practice’s ability to perform cancer
diagnosis may be improved.
Trial registration: Registered as NCT02069470 on ClinicalTrials.gov.
Keywords: Denmark, General Practice, Continuing Medical Education, Diagnosis, Early Detection of Cancer, BarriersBackground
Denmark lags behind many European countries in cancer
survival. It has been suggested that late diagnosis and more
advanced cancer stage at treatment lie at the root of this
problem [1-9]. In order to minimise the time from referral
to diagnosis, some countries have implemented fast-track* Correspondence: berit.toftegaard@feap.dk
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article, unless otherwise stated.pathways for cancer, e.g. the 2-week wait in the United
Kingdom and the cancer pathways in Denmark [10,11].
Such organisational initiatives are largely dependent on
the prevailing referral patterns in general practice.
Selecting patients for referral for suspected cancer is a
complex procedure which is influenced by 1) the gen-
eral practitioner’s (GP’s) personal characteristics such
as knowledge, skills, clinical judgement, risk-taking dis-
position and attitude; 2) organisational factors such as
access to tests and investigations; and 3) patient-related
factors such as expectations, symptom presentation andtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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straightforward task to set the bar for referral [12]. Over-
investigation has clinical and financial consequences,
whereas under-investigation may delay diagnosis and have
medico-legal implications.
The key role of general practice in earlier cancer diag-
nosis is indisputable; 85% of Danish cancer patients pre-
sented symptoms to general practitioners on their route
to diagnosis [13]. Previous studies have found that can-
cer patients had an increased number of visits to general
practitioners 6 months prior to diagnosis [14] and that
25% of all cancer patients had a primary care interval of
more than 20 days until referral according to the GPs
[15,16]. Thus, there seems to be a potential for earlier
referral and possibly also for earlier diagnosis [17-21].
However, as the average Danish GP sees only eight to
ten new cancer patients per year, cancer is a relatively
rare disease in primary care. Half of the diagnosed can-
cer patients are known to present with what the GPs re-
port as alarm symptoms, while the other half tend to
present with non-specific or vague symptoms [13,15].
When patients present cancer-related symptoms to gen-
eral practitioners, their probability of having cancer is
low because even alarm symptoms of cancer have low
positive predictive values (PPVs; below 5%) [22-30]. Yet,
the proportion of cancer patients among patients re-
ferred to cancer fast-track pathways is high (PPVs of
10%–30%) [31,32], which implies that the GPs may
somehow introduce a higher threshold for referral.
To improve cancer diagnostics in Denmark, the latest
Danish Cancer Plan included continuing medical educa-
tion (CME) targeting GPs as a key strategy to optimise
cancer symptom recognition among GPs and to facilitate
referral to fast-track pathways. The CME initiative pro-
vided an important opportunity to measure if and how
targeted CME may influence the participating GPs’
knowledge, attitude and activity in the context of referral
for cancer suspicion.
The primary aim of this article is to describe the con-
ceptualisation, operationalisation and implementation of
CME to enhance cancer diagnostics in primary care. A
second aim is to describe the study design and outcomes




The study was performed in one of the five Danish
Regions (Central Denmark Region) which has 1.27 million
inhabitants and 417 GP clinics with 836 GPs. In Denmark,
GPs own their private clinics and are on a contract with
the Danish Regions on a central, negotiated scheme [33].
Part of this scheme includes remuneration for participa-
tion in CME. As a first line in the Danish healthcaresystem, the GPs provide free access to medical advice and
act as gatekeepers to hospital and private specialists. Each
citizen (99%) is listed with a specific general practice
clinic.
The regional CME on early cancer diagnosis was initi-
ated by a team comprising researchers, a regional aca-
demic coordinator, hospital-GP liaison advisors, a CME
supervisor and three leading hospital consultants. A work-
ing group was established to operationalise the CME. This
group counted four academic GPs of whom two were
hospital-GP liaison advisors, one CME supervisor and one
researcher (BST). A research group (the authors) identi-
fied the barriers as described below. The Danish govern-
ment funded the CME.
Identification of barriers at GP level for early cancer
diagnosis
The key aim of the CME was to optimise cancer-related
referral from general practice clinic to hospital in an at-
tempt to identify underlying cancers at an earlier and
more amenable stage. The target for the intervention
was the individual GP, and the CME was developed in a
stepwise manner as described by Grol et al. [34]. Ini-
tially, the research group identified barriers at the GP
level for early referral using a number of methods: input
from research literature, brainstorm among the four GPs
in the working group, individual GP interviews made by
the first author (BST), a focus group interview with six
GPs [35], experiences from audit of lung cancer diagno-
sis in general practice in the UK [36], and Danish GPs’
responses to the Module 3 International Cancer Bench-
marking Partnership (ICBP) questionnaire [37]. The bar-
riers identified through this process were shared with
the members of the working group, and they were in-
cluded in the CME if considered both important and
possible to change (Figure 1).
One barrier was “Insufficient GP knowledge about
the positive predictive values (PPV) of cancer symp-
toms”. This barrier signifies that GPs have not acquired
full knowledge of the PPVs based on primary care pop-
ulations [22-27,38]. It was hypothesised that this could
prevent GPs from knowing what would be the PPV
upon referral of patients to the fast-track cancer path-
way (below 10%). Another barrier was “Lack of recogni-
tion of the ‘low-risk-but-not-no-risk’ symptoms”. This
barrier reveals the absence of awareness of non-
specific, vague symptoms [39,40]. “Lack of knowledge
on benefits of early diagnosis” suggests an insufficient
understanding of the fact that 2–4 weeks’ delay in diag-
nosis may cause stage progression for some cancers
[41] and that waiting time in general can have an im-
pact on prognosis [8,42]. Another important issue,
“false reassurance from a normal test and other pit-
falls”, covers the fact that GPs felt reassurance when an
Figure 1 The process of identifying the important barriers to be included in the CME program.
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indications. This reassurance could arise because of the
false negative nature of the results (e.g. chest x-ray missing
15-20% of lung cancers [43]) or because a negative test re-
sult was used to exclude a cancer diagnosis (e.g. normal
blood counts). Awareness of typical pitfalls [44] in early
cancer diagnosis was thus considered important to the
GP’s choice and interpretation of a test.
“High risk-taking” indicates the existence of a high
GP referral threshold [45]. The threshold is considered
to be too high since the observed proportion of cancer
patients in Danish fast-track pathways (typically 10-
30%) [31,32] is higher than the PPVs of alarm symp-
toms. “Low use of fast-track pathway referral for cancer
suspicion” indicates that in some situations GPs refer
patient to an ordinary hospital investigation rather than
to the more optimal cancer fast-track pathway. This
could be explained by an incomplete implementation
or a concern for overuse of the fast-track referral op-
tion. “Inadequate experience with online cancer guide-
lines” indicates a need for more experience in the useof the regional website for referral. It was hypothesised
that such a website would heighten the GPs’ knowledge
about referral criteria and receiving departments and
that the presence of this website would allow the GPs an
opportunity to better inform the patient about the investi-
gation and overall reduce time spent. “Difficulties in com-
municating cancer risk” concealed an uncertainty in how
to communicate risk to a patient. This item was evaluated
as important since, opposite ordinary referral, referral to a
fast-track pathway required that the GP informed the pa-
tient about their suspicion of cancer. Thus, some GPs did
not refer patients to cancer fast-track investigation as they
did not want to worry the patient.
Addressing the identified barriers and developing the CME
elements
According to the theoretical frame described by Michie
et al. [46], any changes in the GP’s clinical behaviour (B)
will be governed by their psychological and physical cap-
ability (C), social opportunity (O) and motivation (M) to
change. Using this COM-B-model, the identified barriers
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quently developed (Table 1).
The psychological capability is the GP’s ability to en-
gage in the necessary thought processes related to com-
prehension and reasoning. The cognitive part of the
CME would increase the GP’s knowledge about the
PPVs of cancer symptoms and increase his or her aware-
ness of the identified pitfalls in cancer diagnosis. This was
believed to lead the GP to perform a more correct cancer
risk assessment and thereby optimise referral procedures.
The CME would point out that referral-delay could
worsen the prognosis to dispel the myth that cancer de-
velops over several years and that another month there-
fore would not change the prognosis [8,47].
The physical capability covers the skills necessary to
perform concrete manoeuvres. The CME reintroduced
how to access the regional website and shortly de-
scribed the contents and search tool. Furthermore, the
communication skills about cancer were addressed
through case-based discussion on how and when to in-
form a patient about cancer risk.Table 1 The operationalisation of the specific CME elements b
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The CME-elements were approached by capability, opportunity or motivation (COMThe GPs’ physical opportunity to refer patients sus-
pected of having cancer exists through the already estab-
lished fast-track pathways and existing guidelines. The
CME included no intervention in this area. The social op-
portunity was indirectly addressed by including a local
opinion leader and a local hospital consultant in the team
of lecturers to emphasise that a change of attitude towards
lowering the referral threshold is widely recommended.
Motivation includes the reflective processes involving
evaluation. Risk taking was addressed through case-
based discussion and by raising questions about what it
implies to be a competent GP. Motivation also com-
prised automatic processes involving emotions and im-
pulses arising from associative learning. To address
these processes, the CME included an educational film
developed to illustrate a GP’s handling of a patient with
a complex medical history. By identifying with the GP
actor and by subsequently discussing his struggle and
lack of readiness to do the definitive investigation, it
was intended that the GPs would store this experience
in their mind for later pattern recognition.ased on the identified barriers
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The CME took place as a 3-hour session. According to
the available evidence, the teaching approach was multi-
faceted, partly didactic, but mostly interactive [48,49].
The key points were first explained and illustrated by an
oral presentation, next they were discussed in a reflective
debate based on two clinical patient scenarios and one
educational film to create a scenario similar to that
encountered in clinical practice and decision-making.
Hands-on models of tumours were placed in the lecture
room. PPV diagrams on lung, colorectal, ovarian and
prostate cancer [22-27] were printed in hard copy as a
clinical tool. Furthermore, leaflets for specific fast-track
pathway to support communication about risk of can-
cer were offered in a plastic retainer, also to bring home
to the clinic. The CME schedule is shown in Table 2.
Lecturers
The CME sessions were conducted by a team of six
persons with different healthcare backgrounds. They
consisted of an academic primary care researcher to in-
crease the new evidence-based knowledge; two hospital-
GP liaison advisors to reduce the gap between research
knowledge and everyday life in practice; a local CME
supervisor to establish a safe atmosphere and to facilitate
acceptance of the knowledge by being considered a local
opinion leader; a local hospital consultant to guarantee
that the proposed changes could be anchored locally and
to ensure a debate of any local issues that could act as bar-
riers to the implementation. A regional academic coordin-
ator introduced the program and ensured that time was
kept.
Lecture room
The CME was intended to reach as many GPs as pos-
sible in the Central Denmark Region. Geographical
accessibility was therefore important, and the CME
sessions were accordingly arranged as eight local meet-
ings. The meeting rooms had high-quality audio-visual
equipment and were laid out with round tables for 6–8
people. Participants were offered catering during the meet-
ing, and a friendly, relaxed atmosphere was established.
Piloting
A full-scale CME session was conducted with the Regional
Cancer Steering group as audience. Feedback from the
session was used to further adapt the CME.
Study design
The effect of the CME intervention will be evaluated in a
geographical cluster randomised stepped wedge design
[50]. All GPs in the Central Denmark Region were allo-
cated to one of eight clusters based on their clinics’ geo-
graphical location. CME was offered as a 3-hour meetingto each cluster with 3 weeks’ interval in between clusters.
Clusters with delayed intervention will serve as controls
for clusters that have already received interventions
(Figure 2).
The Regional Cancer Care Unit generated the random
allocation sequence which was based on the pragmatic
principle that dates for CME should be applicable for that
geographical area (taking into account other arrangements
in the area, the availability of venue, etc.). The same inde-
pendent administrative unit enrolled and assigned clusters
to the CME. The researchers were not involved in the ran-
domisation. The GPs were not aware of the interventional
design. The main researcher was present at the meeting,
but only to register participants and to observe that the
CME was delivered as planned to evaluate uniformity. She
could not interfere with the participants or the CME
conduct.
Study population and recruitment of GPs to the CME
All GPs from the Central Denmark Region were invited
to the CME. The CME was announced in each cluster
by mail invitations 2 months before and again 1 month
before the CME. Additionally, the description of the
meeting was available on the regional GP website. Each
GP willing to participate in the CME was registered at
sign-up and again upon arrival at the CME.
Inclusion and exclusion criteria for patients
Included are all patients referred from general practice
to the fast-track pathway for cancer except patients sus-
pected for non-melanoma skin cancer. Excluded are pa-
tients already diagnosed with cancer within five years
prior to the date of referral.
Outcomes
The primary outcomes
1) Primary care interval is defined as the time from the
first presentation of a cancer-relevant symptom in
primary care until the date of referral to secondary
care for investigation [16]. It was hypothesised that
the CME would lower the primary care interval by
increasing the GP’s readiness to refer.
2) GP referral rate is defined as the number of patients
referred by a specific GP to a cancer fast-track path-
way per 1000 patients listed with the GP. The CME
was expected to increase the referral rate.
The secondary outcomes
1) GP knowledge is defined as knowledge on i) Cancer
as a condition with a low prevalence, ii) PPVs for
cancer of selected symptoms, iii) Typical pitfalls and
iii) Initial cancer presentation. This is measured by
Table 2 The schedule for the 3-hour CME meeting provided in the eight clusters
Time
(minutes)
Form Lecturer Barriers Content
10 Introduction Regional academic
coordinator
Presentation of schedule and lecturer
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Plenary discussion Risk-taking Early stage—vague symptoms
Use of fast-track
referral
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Communicating
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10 Group discussion GP participants Debate: How are diagnostics done in your clinic?
10-min break (hands-on models were introduced)
40 Educational film Hospital-GP
liaison advisors
Risk-taking Educational film discussed in sequences
Group discussion GP participants Use of fast-track
referral
Awareness of barriers, pitfalls and difficulties in an
everyday general practice setting.
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Debate on patient cases










Reintroduction of regional GP homepage.
Communicating risk Leaflets to support communicating cancer risk
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percentage (0-100%) on questions such as; what is
the likelihood of a 50-year-old patient having cancer
at the time you choose to refer to a cancer fast-trackpathway? What is the likelihood of a patient, smoker,
aged 40 and above, having lung cancer the second
time the patient presents with haemoptysis in your
practice? What is the risk for a lung cancer not being
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Figure 2 The stepped wedge design to evaluate the effect of the CME. The first time point to the left indicates the baseline measurement
where all of the clusters were controls (C). At subsequent time points, clusters received the CME intervention and crossed over to interventions
(I). All clusters eventually received the intervention. The bottom of the figure focuses on one cluster to illustrate the data collection and the three
subgroups for stratification: 1) GPs who participated in the CME; 2) GPs who did not participate in the CME, but who had at least one colleague
who participated; 3) GPs who did not participate in the CME and who had no colleagues who participated.
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What is the proportion of patients with colorectal
cancer who initial presented an alarm symptom?
2) GP attitude towards early cancer diagnosis, assessed
as a score on a 1–5 Likert scale. It is defined as
attitude to i) Use of fast-track referral, i.e. whether
the referral option is considered complicated and/or
time-consuming. ii) Use of healthcare resources, i.e.
whether risk taking is affected by fear of overuse or fear
of delayed diagnosis. iii) Use of patient resources, i.e.
whether risk taking is affected by fear for unnecessary
distress or need for necessary investigation to find
those with cancer in an early stage.
3) GP self-assessed readiness to refer is defined as the
proportion of hypothetical patients referred at their
first presentation based on GP responses to patient
scenarios (vignettes) concerning cancer diagnosis.
4) GP-assessed risk of cancer for referred patients.
5) Referred patients’ GP visit rates 6 months prior
to diagnosis compared with their earlier use of
general practice. 6) The proportion of patients with
cancer among referred patients for each GP (GP’s
PPV for diagnosing cancer when a patient is
referred to the cancer fast-track pathway). 7) Cancer
patients’ clinical tumour stage at the time of
initiating treatment. 8) Cancer patients’ one-year
survival measured as the proportion of cancerpatients per GP alive one year after the date of
diagnosis (Figure 3).
Data
Data are collected by GP-completed online question-
naires before and after the CME and by GP-completed
one-page forms on each patient referred to cancer in-
vestigation within an 8-month period surrounding the
CMEs. These data will be expanded with register data.
Online questionnaire: Development, pilot testing and data
collection
The online questionnaire consisted of vignettes and dir-
ect questions. The vignettes were validated and tested in
the ICBP module-3 studies [37]. They were developed to
describe the likely GP actions which included GP readi-
ness to refer when a patient presented with symptoms
suggestive of lung cancer (two vignettes), colorectal can-
cer (two vignettes) or ovarian cancer (one vignette). GPs
were asked to complete two randomly chosen vignettes.
Each vignette had two or three phases: phase one repre-
sented the first patient presentation; phases two and
three represented subsequent visits where the patient’s
symptoms had developed; each phase had a defined PPV
for cancer.
The direct questions were based on the elements of
the CME developed as ad hoc questions to measure a
Figure 3 The aspects of the interventions that were measured and the outcomes. The first column depicts the elements in the change
process; the second column classifies the corresponding outcomes; the third column describes the methods applied; and the fourth column
depicts the data sources.
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tude (13 items). The first version of the questionnaire
was developed by the authors and academic GPs in an
iterative process that focused on the specific elements
for CME intervention. The questionnaire was piloted
for cognitive understanding among six doctors and, finally,
among 12 GPs. Data quality, missing variables, and ceiling
and floor effects were checked, and a revised version of
the questionnaire was produced (Additional file 1).
The GPs were allocated a CME date. The invitation
to the online questionnaire was sent by e-mail to the
GPs 1 month before the CME. Non-responders re-
ceived a reminder by e-mail after two weeks. A second
questionnaire similar to the first one except for two
new randomly selected vignettes was sent by e-mail
7 months after the CME to GPs who responded to the
first questionnaire. Non-responders were reminded by
e-mail after two weeks.
One-page forms on referred patients: Development, pilot
testing, and data collection
This form was used to collect specific clinical informa-
tion on patients referred from GPs to the fast-track
pathway on cancer suspicion. The one-page form re-
quested the patient’s personal identification number, thedate of hospital referral, the date of first presentation of
symptoms in general practice related to cancer suspi-
cion, the symptoms presented at the time of referral, the
specific fast-track pathway, and the GP’s assessment of
the patient’s risk of cancer. GPs were asked to rate a spe-
cific risk for cancer by indicating a probability percent-
age (0–100) (Additional file 2).
All the items mentioned above have previously been
validated in studies performed by the Research Unit
[15,44]. The form was piloted in three steps. Seven GP
trainees were observed while they filled in the form
about the most recent patient they had referred on can-
cer suspicion. They were interviewed about any prob-
lems encountered and how they understood the items.
Three GPs then completed forms in their daily practice
over a 2-week period in order to check its feasibility. Fi-
nally, 21 GPs were asked to fill out and subsequently
send the forms electronically to the Research Unit to
verify the feasibility of the electronic transfer and the op-
tical scanning of the forms [51].
In August 2012, all GPs in the Central Denmark Region
received a pad with 25 forms. They were requested to
complete a form each time they referred a patient to a
cancer fast-track pathway within an 8-month period
(September 2012-May 2013). Patients referred to fast
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in a radiological database (breast cancer). If the GP form
was missing, the GP was sent a form for the particular pa-
tient and kindly requested to complete it. This form was
extended with an item on the patient’s route into a fast-
track pathway investigation to include only patients re-
ferred from GPs on cancer suspicion (Additional file 3).
The one-page form was designed and processed in the
computer programme Teleform Enterprise Version 8.0
(Cardiff software Inc., San Marcos, CA, USA). Handwrit-
ten data including presenting symptoms were coded by
the first author (BST) before scanning [51].
All data will be transferred to the statistical program
Stata (Stata software, version 11.1, StataCorp, College
Station, Tex, USA) and will be checked for errors. If er-
rors are encountered, the original form of the completed
questionnaire will be inspected, and the database entry
will be corrected.Incentives
Remuneration was 33 Euros for completing the first on-
line questionnaire and 17 Euros for completing the sec-
ond online questionnaire. The GPs received 100 Euros
for completion of forms on referred patients during the
8-month period.Register data
Each inhabitant with a permanent residence in Denmark
has a 10-digit personal identification number, the CPR
number. This number is registered in the Danish Civil
Registration System and allows linkage between all na-
tional registries at the individual level. A cancer patient’s
vital status will be obtained 12 months after the date of
diagnosis.
The provider number registry contains the names and
addresses of every Danish GP, the number of GPs in
each general practice, and patient list size including the
patients’ sex and age.
The Primary Care Referral Registry (an online data-
base) stores copies of all electronic referral letters sent
from general practice to hospital. We will develop an al-
gorithm to identify patients referred on cancer suspicion
in the 8-month study period to increase the complete-
ness of the data on referred patients.
The Danish National Patient Registry [52] will be used
to obtain information about comorbidity and cancer
diagnoses.
The Danish National Health Service Registry [53] will
be used to count the number of contacts of referred pa-
tients to general practice during the 6 months preceding
the referral date. Each patients previous use of general
practice patient will be counted and serve as a basis for
comparison.The Danish Cancer Registry [54] will be used to iden-
tify patients with cancer among all referred patients.
From this registry, we will also obtain data on date of
diagnosis, cancer type and tumour stage.
Statistics Denmark [55] holds data stored in the Inte-
grated Database for Labour Market Research. These data
will be used to calculate a deprivation score for each
general practice (Table 3).
Statistical analyses
For the descriptive part, differences will be tested using
appropriate parametric and nonparametric statistics. The
effect of the intervention will be analysed in a generalised,
linear, random-effects model with random effect of GPs.
The data will be used to assess whether further modelling
of inter-correlation within practice and within clusters is
required, and whether the intervention effects are equal
for all GPs or in random interaction with them. Ana-
lyses will be performed both in the full GP population
“intention to intervene” (cluster level) and in the three
GP subgroups: 1) GPs who participated in the CME, 2)
GPs who did not participate in the CME, but had at
least one colleague who participated, and 3) GPs who
did not participate in the CME and who had no col-
leagues who participated. A colleague is defined as a
GP with the same clinic address as the respondent. The
intervention effect on GP knowledge and attitude will
be measured in a before-after analysis.
Power calculation
Power calculation is based on the primary outcome: Pri-
mary care interval. The sample size is calculated to detect
a reduction in the longest primary care intervals >20 days
[56] from 25% to 20%. The expected effect is reduced ac-
cording to an intervention to intervene analysis; we expect
a GP participation rate at the CME-meetings of 40%. Un-
corrected for clustering and repeated measures, a total
sample size (N) of 5116 patients would be required (power
of 99% and significance level of 0.05).
To accommodate the stepped wedge clustering effect
N has to be multiplied by the design effect (DE) [57]:
Nsw = DE*N, where
DE ¼ 1þ ρ ktnþ bn−1ð Þ
1þ ρ 12 ktnþ bn−1
   3 1−ρð Þ
2t k− 1k
 
Here, ρ is the intra-cluster correlation, k is the number of
steps, n is the average cluster size, b is the number of
baseline measurements and t is the number of measure-
ments after each step. In our study k = 8, b = t = 1. Fur-
thermore, we assume that ρ = 0.05, as it is a typical value
for intra-cluster correlation for clinical outcomes in pri-
mary care [58]. The cluster size can be expressed as n =
Nsw / c, where c is the number of clusters. The number of
Table 3 Detailed description of registers used for data collection to investigate the effect of the CME
Name of register Description of registers
The CPR number and the Danish
Civil Registration System (CRS)
In Denmark (and other Nordic countries), researchers have exceptional opportunities to perform register-based
research because every person with a permanent residence in Denmark has a unique personal identification
number. At birth or immigration, all citizens in Denmark are allocated a personal ten-digit identification number,
the CPR number. This number is registered in the Danish Civil Registration System (CRS) and allows linkage
between all national registries at the individual level. The CRS contains information about vital status (dead or
alive) and residence.
The Primary Care Referral Registry An online shared database with all electronic referral letters sent from general practice clinics to hospitals.
Contains information about sender, receiver and patient including anamnesis. We will develop an algorithm to
identify patients referred for cancer investigation.
The Danish National Patient
Registry(NPR) comprises The
Patient Administrative System (PAS)
The NPR is a national database unifying information from the five regional Patient Administrative System (PAS).
The NPR is run by the National Board of Health who carries out ongoing validation of the data from PAS. Both
the NPR and PAS are continuously updated. They comprise variables like the patient CPR number, dates of
admission and discharge, diagnoses classified according to the International Classification of Diseases (ICD-10)
(Comorbidity), codes for undertaken procedures, the GP’s provider number and different additional codes. Of
particular relevance for this study, we identified patients referred to fast-track cancer pathways by the additional
code DZO31 in PAS every second week.
List of patients referred to fast-track
pathway for breast cancer from
four radiological departments
Since patients referred to the fast-track pathway for breast cancer are not registered with a DZO31 code, like
other investigations in fast-track pathways, an additional data list was periodically received from the four
radiological departments in Central Denmark Region.
The Danish Cancer Registry (DCR) The DCR has been recording primary cases of cancer on a nationwide basis since 1943 and has been shown
to be accurate and to have a nearly complete registration of cancer cases. The files of the DCR provide
information on cancer type, site morphology and history of cancer. Tumours in the registry are coded
according to the ICD-10 (seventh revision before 2004), which includes a four-digit code for tumour
morphology. If a person develops more than one primary tumour, each tumour is generally registered and
counted as an individual record. We used the DCR to find prior and incident cancer diagnoses among referred
patients and to obtain information on date of diagnosis and tumour stage.
Danish National Health Service
Registry (NHSR)
The NHSR for primary care is a national register of all health professionals contracted with the tax-funded
health-care system, e.g. GPs. The register is run by the National Board of Health, and its data are based on the
health professionals’ invoices to the regional health administrations. Among others, the NHSR holds information
on name and addresses of every provider number. A provider number may refer to several providers if, for
example, several GPs form a medical practice partnership.
Patient list List of patients connected to each provider number. The list contains information on patients’ CPR number,
including age and sex.
The provider number and the
Provider Number Registry
Every health professional contracted with the tax-funded health-care system has a provider number. The
provider number system is used to control the supply of GPs and, to a certain extent, to control expenditures.
GPs are allowed to sell or share their provider number and office facilities. GPs can choose to work in solo
practices or in group practices (in the latter case, the GPs can share a provider number or have one provider
number per GP). Danish citizens are free to choose their own GP unless the GP list is closed (GPs are allowed to
close their lists when the number of persons on the list reaches 1,600 persons). The list system enables the GP
to develop a better knowledge of the individual patient which ensures continuity of care. The Provider Number
Registry contains information on the name and addresses of every health professional with a provider number.
Statistics Denmark As a central authority, Statistics Denmark is responsible for collecting, processing and publishing statistical
information and for making statistical analyses and prognoses. Researchers can apply for data from Statistics
Denmark for further analysis. We will use data from the Integrated Database for Labour Market Research which
is owned by Statistics Denmark to calculate a deprivation score for each GP’s practice population. This Danish
deprivation index (DADI) has eight variables that are scored individually and sum up to a score between 10 and
100; the higher the number, the greater the extent of deprivation in the practice population. The variables used
are (i) proportion of adults aged 20–59 with no employment, (ii) proportion of adults aged 25–59 with
no professional education, (iii) proportion of adults aged 25–59 with low income, (iv) proportion of adults aged
18–59 receiving public welfare payments (transfer income or social benefits), (v) proportion of children from
parents with no education and no professional skills, (vi) proportion of immigrants, (vii) proportion of adults
aged 30+ living alone and (viii) proportion of adults aged 70+ with low income (= the lowest national quartile).
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how many subjects per cluster should be sampled to pro-
vide the power required. Using the equations described
above, this cluster size is estimated as n = 200 through an
iterative procedure. Therefore, the total sample required
(Nsw) is 1,653. In Central Denmark Region, 5,400 new
cancer patients are expected in an 8-month period. Weassumed that 40% [59] of those (2,200) will be referred
from general practice to a cancer fast-track pathway. With
an assumed PPV for diagnosing cancer in fast-track path-
way on 20% and an assumed GP response rate on 70%, we
expect to receive one-page forms with information on pri-
mary care intervals on 7,700 patients. Thus, it is consid-
ered that the study has ample strength—also in relation to
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tiple predictors.
Ethical approval
The Danish Research Ethics Committee (j.no. 10/2014)
concluded that no approval is necessary. The study
was approved by the Danish Data Protection Agency (j.no.
2009-41-3471). The Danish National Board of Health gave
legal permission to obtain information from the GPs’
medical records without permission from the patients
(j.no. 3-3013-149/1/HKR). The regional Data Protection
Agency gave permission to use the regional database
(PAS) and the radiological database to obtain informa-
tion on patients investigated in a cancer fast-track path-
way (j.no. 1-16-02-262-12). The study is registered as
NCT02069470 on ClinicalTrials.gov.
Trial status
The study is ongoing. The CME meetings were con-
ducted in the period September 2012 to May 2013. We
have not yet conducted data cleaning or obtained data
from registers; only the data from forms and question-
naires have been collected. Furthermore, we have not
yet developed the algorithm to identify referred patients
from the Primary Care Referral Registry.
Discussion
We developed a multifaceted CME in early cancer diag-
nosis targeting the individual GPs using a step-wise ap-
proach for the development of complex interventions
[34]. We identified key elements and analysed them by
using the COM-B system described by Michie et al.
[46]. The effect evaluation will be conducted in a geo-
graphical cluster randomised stepped wedge study.
The effect of the CME will be measured at three
levels: GP knowledge and attitude, GP activity and pa-
tient outcomes.
Strengths and limitations of the study
With a detailed description of the CME elements, training
process and context, we have tried to optimise the possi-
bilities for an adaptation/replication in other settings.
The time frame of the present study did not afford us
with the possibility to conduct an explorative study on
the target group before the trial; instead, a full-scale
CME was conducted in an external regional cancer
steering group, and the findings were subsequently
evaluated, discussed and approved.
Randomising individual GPs to the CME intervention
was considered unfeasible as much of the effect would
include GPs working together and discussing cancer
diagnosis within practices and in the CME groups. Pre-
venting GPs from participation was considered unethical
since the CME was a part of the Danish Cancer Plan,and it was considered important that all patients could
benefit from an improved clinical practice. A cluster ran-
domised stepped wedge study was thus preferred. Using
this design, we will be able to control for time trends by
allowing contemporaneous comparisons across clusters
at different time periods.
Designing a study in real life, however, raised some
challenges with regard to controlling the intervention. A
specific CME date was offered to all GPs, but they were
free to decide whether they wanted to participate or not.
The collected data will allow us to compare the three
GP subgroups of each cluster at a baseline level to ex-
plore potential selection bias.
GP knowledge, attitude and self-assessed readiness to
refer will be measured by online questionnaires before
and after the CME to allow paired analyses to be per-
formed. The GPs were informed in the invitation letter
that the questionnaire attempted to measure activity re-
lated to cancer diagnosis in general practice. This could
have influenced the responses.
By placing a pad with forms in each GP office and by
sending regular reminders (every second week), we ex-
pect to collect prospective data, i.e. to obtain data before
the GPs know whether the referred patient had cancer
or not. In cases where the GP forgot to complete a form
and had to be requested to do so, information bias can
occur. Furthermore, lead time bias will be considered
when reporting the 1-year survival. This outcome will be
evaluated in close relation to potential change in cancer
stage.
Conclusions
We have developed a theory-based CME in early cancer
diagnosis. We have described the CME to allow our
intervention to be replicated. We have outlined the
geographical cluster randomised stepped wedge design
chosen for measuring the effect of the CME. If the
CME has an impact on the chosen outcomes, the
model used for its development may be used in similar
primary health care setting.
Additional files
Additional file 1: The ad hoc questions developed to measure a
possible CME effect on GP knowledge and GP attitude.
Additional file 2: One-page form on a referred patient.
Additional file 3: Reminder: One-page form on a referred patient.
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